{"id":"W2601920003","doi":"10.1200/jco.2017.35.6_suppl.173","title":"Phase Ib study of apalutamide (APA) with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Update on safety and efficacy.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Abiraterone acetate; Internal medicine; Taxane; Enzalutamide; Prednisone; Adverse effect; Cancer; Gastroenterology; Urology; Androgen receptor; Oncology; Androgen deprivation therapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001013721,0.0009018208,0.00173421,0.0005153811,0.0003438257,0.001158847,0.0008216614,0.0008679818,0.002974566],"category_scores_gemma":[0.0008568975,0.0005411354,0.001114707,0.0006368525,0.0007010074,0.0007820834,0.0003362742,0.002419683,0.0008631073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008737397,"about_ca_system_score_gemma":0.001644072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001174241,"about_ca_topic_score_gemma":0.002696258,"domain_scores_codex":[0.9996246,0.0001800405,0.00002988507,0.00005440568,0.00005163332,0.00005943973],"domain_scores_gemma":[0.9994065,0.00007930965,0.0001417079,0.00004326689,0.00004103417,0.0002883448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6567729,0.05516324,0.01072289,0.001600488,0.002571773,0.0004839246,0.0004029845,0.003164739,0.05581297,0.0004738908,0.004234816,0.2085954],"study_design_scores_gemma":[0.3862602,0.5818682,0.01586854,0.0001166755,0.000987894,0.001261473,0.0001256932,0.001520636,0.005927921,0.0003509465,0.005672873,0.0000390285],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862732,0.006842678,0.0007546396,0.0004594833,0.0001285217,0.001905171,0.00102854,0.0001162969,0.002491425],"genre_scores_gemma":[0.9886006,0.004425175,0.001486073,0.0005783084,0.0001422208,0.001356939,0.002077628,0.00002550565,0.001307574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002974566,"threshold_uncertainty_score":0.009950936,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.10375789579385,"score_gpt":0.479158247350578,"score_spread":0.3754003515567281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}